SML1144

Noopept

≥98% (HPLC)

• Synonym(e): 1-(2-Phenylacetyl)-L-prolyl-glycine ethyl ester, GVS 111, N-Phenylacetyl-L-prolylglycine ethyl ester, SGS 111
• Empirische Formel (Hill-System): C₁₇H₂₂N₂O₄
• CAS-Nummer: 157115-85-0
• Molekulargewicht: 318.37
• NACRES: NA.77
• PubChem Substance ID: 329825678
• UNSPSC Code: 12352200
• MDL number: MFCD00941121
• Assay: ≥98% (HPLC)
• Form: powder

Eigenschaften

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• optical activity: [α]/D -115 to -125°, c = 0.5 in chloroform-d
• drug control: Új pszichoaktív anyag / New psychoactive substance (Hungary), 78/2022. (XII. 28.) BM rendelet
• color: white to beige
• solubility: DMSO: 20 mg/mL, clear
• shipped in: wet ice
• storage temp.: −20°C
• SMILES string: O=C(CC1=CC=CC=C1)N2CCC[C@H]2C(NCC(OCC)=O)=O
• InChI: 1S/C17H22N2O4/c1-2-23-16(21)12-18-17(22)14-9-6-10-19(14)15(20)11-13-7-4-3-5-8-13/h3-5,7-8,14H,2,6,9-12H2,1H3,(H,18,22)/t14-/m0/s1
• InChI key: PJNSMUBMSNAEEN-AWEZNQCLSA-N

Beschreibung

Biochem/physiol Actions

Noopept is a nootropic and neuroprotective drug that normalizes the balance of the pro- and antioxidant systems.

Noopept is a nootropic and neuroprotective drug that normalizes the balance of the pro- and antioxidant systems. Noopept modulates a variety of physiological functions including cognition and anxiety. Noopept significantly weakens streptozotocin-Induced diabetes in rats.

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable